Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine

被引：11
作者：
Gringauz M. [1 ]
Rabinowitz R. [1 ]
Stav A. [1 ]
Korczyn A.D. [1 ]
机构：
[1] Dept. of Physiology/Pharmacology, Tel-Aviv University, Sackler School of Medicine
来源：
Journal of Anesthesia | 2001年 / 15卷 / 4期
关键词：
Agonist-antagonist; Analgesia; Buprenorphine; Butorphanol; Cross-tolerance; Cyclorphan; Morphine; Nalbuphine; Opioids; Tolerance;
D O I：
10.1007/s005400170004
中图分类号：
学科分类号：
摘要：
Purpose. The increased use of opioids in the chronic treatment of pain, especially with oncologic patients, encourages the search for drugs with potent analgesic activity, but with minimal induced tolerance and cross-tolerance to morphine. Methods. Four agonist-antagonist opioid derivatives (buprenorphine, butorphanol, nalbuphine, and cyclorphan) were examined. Tolerance to the analgesic effect of the four drugs and their cross-tolerance effects with morphine were evaluated in ICR albino mice by the "hot plate method". Measurements of the analgesic effect were taken before and after chronic treatment (of 14 days duration) with these drugs, as well as morphine. Results. All tested drugs produced tolerance after 14 days of treatment. Chronic treatment with morphine reduced the effects of nalbuphine and cyclorphan, but not those of buprenorphine and butorphanol. After 14 days treatment with buprenorphine and cyclorphan, the analgesic action of morphine was reduced, but this reduction did not occur after butorphanol and nalbuphine treatments. Conclusion. Of the four agonist-antagonists tested, butorphanol seems to be least likely to produce cross-tolerance with morphine.
引用
收藏
页码：204 / 209
页数：5
相关论文
共 19 条
  • [1] Alokesh D., Byron C.Y., The effect of intrinsic efficacy on opioid tolerance, Anesthesiology, 82, pp. 1226-1236, (1995)
  • [2] Young A.M., Kapitsopoulos G., Makhay M.M., Tolerance to morphine-like stimulus effects of mu opioid agonists, J Pharmacol Exp Ther, 257, pp. 795-805, (1991)
  • [3] Young A.M., Steigerwald E.S., Makhay M.M., Kapitsopoulos G., Onset of tolerance to discriminative stimulus effects of morphine, Pharmacol Biochem Behav, 39, pp. 487-493, (1991)
  • [4] Janssen P.A., Jagenau A., Mydriatic activity of analgesics in mice, Experientia, 12, pp. 293-294, (1956)
  • [5] Korczyn A.D., Boyman R., Shifter L., Morphine mydriasis in mice, Life Sci, 24, pp. 1667-1674, (1979)
  • [6] Stav A., Rabinowitz R., Korczyn A.D., Action of opioid agonist-antagonist drugs on the pupil and nociceptive responses in mice, J Anesth, 6, pp. 439-445, (1992)
  • [7] Adler C., Keren O., Korczyn A.D., Tolerance to the mydriatic effect of morphine in mice, J Neural Transm, 48, pp. 43-47, (1980)
  • [8] Kaadan M., Stav A., Rabinowitz R., Shavit S., Korczyn A.D., Tolerance to the mydriatic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine in mice, J Anesth, 8, pp. 297-300, (1994)
  • [9] Reisin T., Pasternak G., Opioid analgesics and antagonists, The Pharmacological Basis of Therapeutics, pp. 521-555, (1996)
  • [10] Pick C.G., Paul D., Pasternak G.W., Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice, J Pharmacol Exp Ther, 262, pp. 1044-1050, (1992)
12